Trial Profile

68Ga-PSMA-11 PET/CT for Screening Prior to 177Lu-PSMA-617 Therapy

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 11 Jul 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Gallium (68Ga) gozetotide (Primary)
Indications Prostate cancer
Focus Adverse reactions

Most Recent Events

15 Jan 2024 Status changed from recruiting to completed.
15 Feb 2023 Study is Interventional, study phase changed phase 3. Masking changed to Open label. Planned number of patients also increased.
15 Feb 2023 Planned number of patients changed from 150 to 250.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com